Drug
Pumosetrag clinical trials
Also written DDP733.
How studies write it
Studies that test it under each name
Studies by the year they started
2 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Dynogen Pharmaceuticals (2) · Edusa Pharmaceuticals, Inc. (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Pumosetrag is read from its arms, and is right about nine times in ten.
Testing it · 3
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)CompletedPhase 2Edusa Pharmaceuticals, Inc.NCT01161602Written as Pumosetrag
- A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in FemalesStatus unknownPhase 2/3Dynogen PharmaceuticalsNCT00547469Written as DDP733
- A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-cCompletedPhase 2Dynogen PharmaceuticalsNCT00215566Written as DDP733
Codes
What other systems call Pumosetrag · ClinicalTrials.gg INT004611
- MeSH (NLM) C482040PumosetragOne source NLM
- UNII (FDA) 1G26B32139PUMOSETRAGConfirmed FDA, NLM, Wikidata
- Wikidata Q27252379pumosetragConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C84126PumosetragOne source FDA
- DrugBank DB12402One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C482040 | Pumosetrag | One source NLM |
| UNII (FDA) | 1G26B32139 | PUMOSETRAG | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27252379 | pumosetrag | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C84126 | Pumosetrag | One source FDA |
| DrugBank | DB12402 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.